A logo sits on a wall inside Johnson Johnson's innovation centre in London UK on Thursday July 18 2013 Secondquarter sales rose 85 percent to $179...
{"Image ImageDescription": "A logo sits on a wall inside Johnson & Johnson's innovation centre in London, U.K., on Thursday, July 18, 2013. Second-quarter sales rose 8.5 percent to $17.9 billion, helped by demand for the company's newer pharmaceutical offerings including the blood thinner Xarelto and the prostate cancer medicine Zytiga. Photographer: Simon Dawson/Bloomberg via Getty Images", "Image Copyright": "2013 Bloomberg"}